首页> 美国政府科技报告 >Combination Chemotherapy Using Immune Modulators and Antiviral Drug against Togaviruses and Bunyaviruses.
【24h】

Combination Chemotherapy Using Immune Modulators and Antiviral Drug against Togaviruses and Bunyaviruses.

机译:使用免疫调节剂和抗病毒药物对结核病毒和布尼亚病毒的联合化疗。

获取原文

摘要

We have studied model arboviruses and arenaviruses to develop effective combination therapies using antiviral drugs and immunomodulators. The compounds were examined using Pichinde' (PIC) an arenavirus; Banzi (BZ) and West Nile (WN), two flaviviruses; Semliki Forest (SF), an alphavirus; and Bunyamwera (BW) and LaCrosse (LAC), two Bunyaviruses. Ribavirin was very effective against PIC, allowing for the development of lasting immunity to reinfection in surviving animals. Interferon (IFN) and IFN inducers had a consistent prophylactic antiviral action against all arboviruses tested, while not affecting PIC infection. The combination of ribavirin and IFN-Alpha/Beta provided a synergistic antiviral effect against BZ, SF, and LAC; tumor necrosis factor (TNF) and IFN-Alpha/Beta provided greater than additive antiviral effect against BZ, while the combination of interleukin-2 with IFN-Alpha/Beta erratic results against the same viruses. Finally, successful combined therapy of SF or BZ infected mice was achieved with poly I:CLC and antibodies, when the intervention was started at the time of virus spread to the target organs. This treatment provided a strong, long lasting immunity in treated animals. Keywords: Immunomodulators; Antivirals; Arboviruses; Arenaviruses; Combination therapy; RAI. (KT)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号